King's College London

Research portal

Placental peptides regulating islet adaptation to pregnancy: clinical potential in gestational diabetes mellitus: • Endocrine & Metabolic Diseases • Gastrointestinal

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)59-65
Number of pages7
JournalCurrent Opinion in Pharmacology
Early online date7 Sep 2018
E-pub ahead of print7 Sep 2018
PublishedDec 2018


King's Authors


Pregnancy involves a progressive increase in insulin resistance and the β-cells must adapt to compensate and prevent gestational diabetes (GDM). In this review we discuss the evidence for placental peptides, including placental lactogen, hepatocyte growth factor, adiponectin and leptin, playing a role in the islet adaptation to pregnancy. The difficulties of translating data from rodent models into human pregnancy are covered and we summarise studies investigating associations between serum placental peptides and GDM risk. In conclusion, current data support important roles for placental peptides interacting to support β-cells during pregnancy, however mechanisms involved in humans are unclear. Further work in humans is required, but placental peptides have clinical potential from both a diagnostic and therapeutic perspective.

Download statistics

No data available

View graph of relations

© 2020 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454